Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer
出版年份 2020 全文链接
标题
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-21
DOI
10.1038/s41598-020-74882-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Re-epithelialization and immune cell behaviour in an ex vivo human skin model
- (2020) Ana Rakita et al. Scientific Reports
- Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors
- (2020) Paul Savage et al. Communications Biology
- Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene
- (2019) Suvimol Niyomnaitham et al. PeerJ
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
- (2019) Margarite D. Matossian et al. BMC CANCER
- Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
- (2019) Gloria V. Echeverria et al. Science Translational Medicine
- Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer
- (2018) Tia H. Turner et al. BREAST CANCER RESEARCH AND TREATMENT
- High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
- (2018) Gloria V. Echeverria et al. Nature Communications
- KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells
- (2017) Meng Jiang et al. Oncotarget
- Patient-derived xenograft (PDX) models in basic and translational breast cancer research
- (2016) Lacey E. Dobrolecki et al. CANCER AND METASTASIS REVIEWS
- A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
- (2016) Alejandra Bruna et al. CELL
- Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
- (2016) Marc Hafner et al. NATURE METHODS
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
- (2015) I Lohse et al. BRITISH JOURNAL OF CANCER
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
- (2015) Zachary C. Dobbin et al. Oncotarget
- PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance
- (2014) B. Tessoulin et al. BLOOD
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer
- (2014) Miriam B. Brandl et al. Molecular Oncology
- Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
- (2014) Peter Eirew et al. NATURE
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Xenome--a tool for classifying reads from xenograft samples
- (2012) T. Conway et al. BIOINFORMATICS
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose
- (2010) Kyle D. Holen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now